‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective-Reference-Cited by-同舟云学术

‘Twenty years of network meta‐analysis: Continuing controversies and recent developments’: A health technology assessment perspective

Published:2024-07-30 Issue:5 Volume:15 Page:731-734
ISSN:1759-2879
Container-title:Research Synthesis Methods
language:en
Short-container-title:Research Synthesis Methods

Author:

Jackson Dan¹^ORCID,Zhang Landan¹^ORCID,Hettle Robert²,Cooper Miranda³

Affiliation:

1. Statistical Innovation Group AstraZeneca Cambridge UK

2. Health Technology Assessment and Modelling Science AstraZeneca Cambridge UK

3. Oncology Biometrics AstraZeneca Cambridge UK

Abstract

AbstractWe respond to some of the methodological issues raised in a recent review of network meta‐analysis (NMA). We also provide a health technology developer's perspective and consider the future application of NMA to health technology assessment.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jrsm.1740

Reference19 articles.

1. Twenty years of network meta‐analysis: Continuing controversies and recent developments

2. The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain

3. A comparison of arm‐based and contrast‐based models for network meta‐analysis

4. A comparison of seven random-effects models for meta-analyses that estimate the summary odds ratio

5. Two new methods to fit models for network meta-analysis with random inconsistency effects

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to discussant comments on “NMA, the first 20 years”;Research Synthesis Methods;2024-07-26